ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,020Medicare Part D Prescriptions Filled, Including Refills

Rank: 189 out of 761

$382K Total Retail Price of All Prescriptions

Rank: 232 out of 761

490 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 490 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,345 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 488 464 1 2
LEVOTHYROXINE SODIUM 373 366 2 3
LISINOPRIL 285 272 3 1
ATENOLOL 271 261 4 8
HYDROCODONE-ACETAMINOPHEN 254 224 S3 5 5
OMEPRAZOLE 251 218 6 4
AMLODIPINE BESYLATE 244 240 7 6
POTASSIUM CHLORIDE 183 176 8 18
FUROSEMIDE 178 151 9 7
CITALOPRAM HBR 138 114 10 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 121 11 35
HYDROCHLOROTHIAZIDE 114 114 12 11
METOPROLOL TARTRATE 113 111 13 14
PREDNISONE 112 92 14 30
METOPROLOL SUCCINATE 112 112 14 16
ZOLPIDEM TARTRATE 105 102 16 22
GABAPENTIN 97 74 17 15
METFORMIN HCL ER 96 96 18 67
WARFARIN SODIUM 95 75 19 9
CRESTOR 93 91 20 36
SYNTHROID 89 76 21 64
SERTRALINE HCL 81 67 22 25
LOSARTAN-HYDROCHLOROTHIAZIDE 78 78 23 65
TRIAMTERENE-HCTZ 75 75 24 42
LOSARTAN POTASSIUM 74 54 25 13
ESTRADIOL 72 57 R 26 80
ALENDRONATE SODIUM 71 71 27 21
ALLOPURINOL 70 68 28 28
LOVASTATIN 66 61 29 17
DIOVAN 66 66 29 58
PRAVASTATIN SODIUM 65 65 31 20
NEXIUM 60 60 32 98
RANITIDINE HCL 53 53 33 52
OXYCODONE HCL 50 30 S2 34 24
AZITHROMYCIN 50 45 34 70
GLIMEPIRIDE 50 46 34 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.